BG
STML

Bellevue Group’s Stemline Therapeutics, Inc. STML Stock Holding History

Bellevue Group’s Portfolio STML Stock Details STML Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-31,500
Closed -$328K – 227
2019
Q3 		$328K Buy
+31,500
New +$328K 0.01% 209